Golden Ally Lifetech Group, Inc. (AQPW) Comparison with companies in other sectors?

Golden Ally Lifetech Group, Inc. has a share price of 7.41B. You can analyze Golden Ally Lifetech Group, Inc. (AQPW) competitors across different market sectors through stock heatmaps.

What are AQPW's NET and operating margins?

Golden Ally Lifetech Group, Inc. (AQPW) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does AQPW's earnings per share (EPS) trend reflect its financial momentum?

Golden Ally Lifetech Group, Inc. (AQPW) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Golden Ally Lifetech Group, Inc. is -0.02, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Golden Ally Lifetech Group, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Golden Ally Lifetech Group, Inc. like P/E which is -0.28, P/B which is 1.07, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Golden Ally Lifetech Group, Inc.

AQPW•PNK

Consumer Defensive

Beverages - Non-Alcoholic

$0.00

$-0.00(-0.00%)

Fundamental Analysis of Golden Ally Lifetech Group, Inc. (AQPW)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.01

P/E Ratio

-0.02

ROE

-7.72%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.48M

Shares OutstandingTotal number of shares issued

$7.41B

Book Value/ShareNet worth per share

$0.00

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-772.01%

ROAReturn on total assets

-352.83%

ROCEReturn on capital employed

-374.21%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.00

Cash/ShareCash and equivalents per share

$0.00

FCF YieldFree cash flow as percentage of market cap

-410.75%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for AQPWFinancial Ratios Analysis details for AQPW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for AQPWSector Benchmarking details for AQPW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Golden Ally Lifetech Group, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Golden Ally Lifetech Group, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Golden Ally Lifetech Group, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Golden Ally Lifetech Group, Inc.

For Golden Ally Lifetech Group, Inc., essential financial indicators include EPS -0.01, PE -0.02, and ROE -7.72. These key ratios reveal insights into Golden Ally Lifetech Group, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Golden Ally Lifetech Group, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Golden Ally Lifetech Group, Inc.

Metrics like Net Margin - and ROA -352.83% shed light on how well Golden Ally Lifetech Group, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Golden Ally Lifetech Group, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Golden Ally Lifetech Group, Inc.

Using ratios such as P/B Ratio 1.07 and PEG Ratio -0.00, investors can assess whether Golden Ally Lifetech Group, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Golden Ally Lifetech Group, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Golden Ally Lifetech Group, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.06 and Cash Flow $-0.00, provide a snapshot of Golden Ally Lifetech Group, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Golden Ally Lifetech Group, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Golden Ally Lifetech Group, Inc.

Investing in Golden Ally Lifetech Group, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Golden Ally Lifetech Group, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;